CY1120793T1 - Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλια - Google Patents
Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλιαInfo
- Publication number
- CY1120793T1 CY1120793T1 CY20181100673T CY181100673T CY1120793T1 CY 1120793 T1 CY1120793 T1 CY 1120793T1 CY 20181100673 T CY20181100673 T CY 20181100673T CY 181100673 T CY181100673 T CY 181100673T CY 1120793 T1 CY1120793 T1 CY 1120793T1
- Authority
- CY
- Cyprus
- Prior art keywords
- methods
- patient
- pharmaceutically acceptable
- treatment
- presented
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 4
- 239000000203 mixture Substances 0.000 abstract 3
- 150000001875 compounds Chemical class 0.000 abstract 2
- 238000011200 topical administration Methods 0.000 abstract 2
- DQUOOKMLOSPCLZ-UHFFFAOYSA-N 3-(4-acetamidophenyl)-2-methoxypropanoic acid Chemical compound COC(C(O)=O)CC1=CC=C(NC(C)=O)C=C1 DQUOOKMLOSPCLZ-UHFFFAOYSA-N 0.000 abstract 1
- 201000004384 Alopecia Diseases 0.000 abstract 1
- 231100000360 alopecia Toxicity 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 210000003780 hair follicle Anatomy 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 230000008929 regeneration Effects 0.000 abstract 1
- 238000011069 regeneration method Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000037390 scarring Effects 0.000 abstract 1
- 210000000130 stem cell Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/65—Tetracyclines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
- A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q7/00—Preparations for affecting hair growth
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Dermatology (AREA)
- Birds (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
Abstract
Στο παρόν παρουσιάζονται μέθοδοι ενίσχυσης της επιδερμικής αναγέννησης σε ένα ασθενή που το έχει ανάγκη, που περιλαμβάνουν την τοπική χορήγηση στον εν λόγω ασθενή μιας φαρμακευτικά αποδεκτής σύνθεσης που περιλαμβάνει Ν-ακετυλο-3-(4-αμινοφαινυλο)-2-μεθοξυπροπιονικό οξύ ή ένα φαρμακευτικά αποδεκτό άλας ή στερεοϊσομερές αυτού, και ένα φαρμακευτικά αποδεκτό έκδοχο. Για παράδειγμα, παρουσιάζονται μέθοδοι για τη θεραπευτική αγωγή ή τη βελτίωση της ουλωτικής αλωπεκίας, που περιλαμβάνουν την τοπική χορήγηση σε ασθενή που το έχει ανάγκη μιας φαρμακευτικά αποδεκτής σύνθεσης που περιλαμβάνει τις ενώσεις που αποκαλύπτονται. Επίσης παρουσιάζονται μέθοδοι για την προστασία των προγονικών κυττάρων των θυλάκων τριχών και συνθέσεις που περιλαμβάνουν αυτά όπου χρησιμοποιούνται οι ενώσεις που αποκαλύπτονται.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261700623P | 2012-09-13 | 2012-09-13 | |
PCT/EP2013/069062 WO2014041140A1 (en) | 2012-09-13 | 2013-09-13 | Methods of treating hair related conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1120793T1 true CY1120793T1 (el) | 2020-05-29 |
Family
ID=49170707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20181100673T CY1120793T1 (el) | 2012-09-13 | 2018-06-28 | Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλια |
Country Status (25)
Country | Link |
---|---|
US (2) | US20150250749A1 (el) |
EP (1) | EP2895160B1 (el) |
JP (1) | JP2015528479A (el) |
KR (1) | KR20150054934A (el) |
CN (1) | CN104837486A (el) |
AU (1) | AU2013314288B2 (el) |
BR (1) | BR112015005467A2 (el) |
CA (1) | CA2883823A1 (el) |
CY (1) | CY1120793T1 (el) |
DK (1) | DK2895160T3 (el) |
EA (1) | EA035986B1 (el) |
ES (1) | ES2675169T3 (el) |
HR (1) | HRP20181000T1 (el) |
HU (1) | HUE037903T2 (el) |
IL (1) | IL237449A0 (el) |
IN (1) | IN2015DN02104A (el) |
LT (1) | LT2895160T (el) |
MX (1) | MX356888B (el) |
NZ (1) | NZ705389A (el) |
PL (1) | PL2895160T3 (el) |
PT (1) | PT2895160T (el) |
SI (1) | SI2895160T1 (el) |
TR (1) | TR201809219T4 (el) |
UA (1) | UA116215C2 (el) |
WO (1) | WO2014041140A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITRM20050389A1 (it) | 2005-07-22 | 2007-01-23 | Giuliani Spa | Composti e loro sali specifici per i recettori ppar ed i recettori per l'egf e loro uso in campo medico. |
UA107562C2 (uk) | 2008-12-05 | 2015-01-26 | Спосіб лікування псоріазу | |
EP2396081B1 (en) | 2009-02-16 | 2017-04-05 | Nogra Pharma Limited | Alkylamido compounds and uses thereof |
MX364220B (es) | 2012-02-09 | 2019-04-16 | Nogra Pharma Ltd | Metodos de tratamientos de fibrosis. |
IN2014DN08157A (el) | 2012-04-18 | 2015-05-01 | Nogra Pharma Ltd | |
WO2020161362A1 (en) * | 2019-02-08 | 2020-08-13 | Nogra Pharma Limited | Process of making 3-(4'-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2396081B1 (en) * | 2009-02-16 | 2017-04-05 | Nogra Pharma Limited | Alkylamido compounds and uses thereof |
IN2014DN08157A (el) * | 2012-04-18 | 2015-05-01 | Nogra Pharma Ltd |
-
2013
- 2013-09-13 BR BR112015005467A patent/BR112015005467A2/pt active Search and Examination
- 2013-09-13 AU AU2013314288A patent/AU2013314288B2/en not_active Ceased
- 2013-09-13 LT LTEP13762485.4T patent/LT2895160T/lt unknown
- 2013-09-13 MX MX2015003278A patent/MX356888B/es active IP Right Grant
- 2013-09-13 US US14/428,164 patent/US20150250749A1/en not_active Abandoned
- 2013-09-13 EP EP13762485.4A patent/EP2895160B1/en active Active
- 2013-09-13 KR KR1020157009052A patent/KR20150054934A/ko not_active Application Discontinuation
- 2013-09-13 WO PCT/EP2013/069062 patent/WO2014041140A1/en active Application Filing
- 2013-09-13 CN CN201380047941.4A patent/CN104837486A/zh active Pending
- 2013-09-13 IN IN2104DEN2015 patent/IN2015DN02104A/en unknown
- 2013-09-13 SI SI201331087T patent/SI2895160T1/sl unknown
- 2013-09-13 HU HUE13762485A patent/HUE037903T2/hu unknown
- 2013-09-13 DK DK13762485.4T patent/DK2895160T3/en active
- 2013-09-13 PT PT137624854T patent/PT2895160T/pt unknown
- 2013-09-13 ES ES13762485.4T patent/ES2675169T3/es active Active
- 2013-09-13 TR TR2018/09219T patent/TR201809219T4/tr unknown
- 2013-09-13 JP JP2015531580A patent/JP2015528479A/ja active Pending
- 2013-09-13 EA EA201590546A patent/EA035986B1/ru not_active IP Right Cessation
- 2013-09-13 NZ NZ705389A patent/NZ705389A/en not_active IP Right Cessation
- 2013-09-13 UA UAA201503407A patent/UA116215C2/uk unknown
- 2013-09-13 PL PL13762485T patent/PL2895160T3/pl unknown
- 2013-09-13 CA CA2883823A patent/CA2883823A1/en not_active Abandoned
-
2015
- 2015-02-26 IL IL237449A patent/IL237449A0/en unknown
-
2018
- 2018-06-28 CY CY20181100673T patent/CY1120793T1/el unknown
- 2018-06-28 HR HRP20181000TT patent/HRP20181000T1/hr unknown
-
2020
- 2020-06-04 US US16/892,513 patent/US20210113505A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
UA116215C2 (uk) | 2018-02-26 |
HRP20181000T1 (hr) | 2018-09-21 |
DK2895160T3 (en) | 2018-06-25 |
MX356888B (es) | 2018-06-18 |
WO2014041140A1 (en) | 2014-03-20 |
PL2895160T3 (pl) | 2018-09-28 |
ES2675169T3 (es) | 2018-07-09 |
IL237449A0 (en) | 2015-04-30 |
TR201809219T4 (tr) | 2018-07-23 |
AU2013314288B2 (en) | 2018-07-05 |
LT2895160T (lt) | 2018-07-10 |
US20210113505A1 (en) | 2021-04-22 |
IN2015DN02104A (el) | 2015-08-14 |
EP2895160A1 (en) | 2015-07-22 |
JP2015528479A (ja) | 2015-09-28 |
EP2895160B1 (en) | 2018-05-30 |
AU2013314288A1 (en) | 2015-03-19 |
NZ705389A (en) | 2018-08-31 |
SI2895160T1 (sl) | 2018-09-28 |
BR112015005467A2 (pt) | 2017-07-04 |
US20150250749A1 (en) | 2015-09-10 |
CA2883823A1 (en) | 2014-03-20 |
EA201590546A1 (ru) | 2015-08-31 |
CN104837486A (zh) | 2015-08-12 |
MX2015003278A (es) | 2015-07-06 |
HUE037903T2 (hu) | 2018-09-28 |
PT2895160T (pt) | 2018-06-29 |
KR20150054934A (ko) | 2015-05-20 |
EA035986B1 (ru) | 2020-09-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1120793T1 (el) | Μεθοδοι θεραπευτικης αγωγης παθησεων που αφορουν μαλλια | |
CY1122483T1 (el) | Λυοφιλοποιημενες παρασκευες μελφαλανης φλουφεναμιδης | |
CY1122186T1 (el) | Μεθοδοι θεραπειας καρκινου | |
CY1122730T1 (el) | 1,2,4-τριαζολες ως διαμορφωτες πυρηνικης μεταφορας και χρησεις αυτων | |
CY1121858T1 (el) | Παραγωγα αρυλμεθοξυ ισοϊνδολινης και συνθεσεις που περιλαμβανουν αυτες και μεθοδοι χρησης αυτων | |
CY1121150T1 (el) | Νευροδραστικα 19-αλκοξυ-17-υποκατεστημενα στεροειδη, χρησιμα σε μεθοδους θεραπειας | |
CY1125292T1 (el) | Παραγωγα 6,7,8,9-tetpaϋδpo-3h-πypazoλo[4,3-f iσοκινολινης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1119058T1 (el) | Ενωσεις ιμιδαζοπυρρολιδινονης | |
CY1119435T1 (el) | Σκευασμα για αντισωμα εναντι- αλφα4βητα7 | |
CY1122624T1 (el) | Θεραπεια συνδυασμου του καρκινου | |
CY1118379T1 (el) | Αναστολεις ιου ηπατιτιδας c | |
CY1120334T1 (el) | Υποκατεστημενης 3-αλλογονοαλυλαμινης αναστολεις ssao και χρησεις αυτων | |
CY1119490T1 (el) | Παραγωγα πυραζολοπυρρολιδινης και η χρηση τους στην θεραπεια νοσηματων | |
CY1119056T1 (el) | Παραγωγα 2',4',-διφθορο-2'-μεθυλ υποκατεστημενου νουκλεοσιδιου ως αναστολεις αντιγραφης hcv rna | |
CY1123627T1 (el) | Παραγωγα διυδροϊμιδαζοπυραζινονης χρησιμα στη θεραπευτικη αντιμετωπιση του καρκινου | |
CY1117986T1 (el) | Ενωσεις αρυλ- ή ετεροαρυλ-υποκατεστημενου βενζολιου | |
MX2018000777A (es) | Compuestos de quinazolina sustituido y su uso como inhibidores de proteinas kras, hras y/o nras mutantes g12c. | |
BR112016012506A2 (pt) | Combinações farmacêuticas, seus usos, e uso de um portador de dados | |
CY1119007T1 (el) | Συνθεσεις και μεθοδοι αγωγης πνευμονικης υπερτασης | |
CY1121538T1 (el) | Μονοκλωνικα αντισωματα εναντι του αναστολεα του μονοπατιου ιστικου παραγοντα (tfpi) | |
CR20170563A (es) | Compuestos de benzoxacepina oxazolidinona y métodos de uso. | |
CY1119410T1 (el) | Βελτιστοποιημενα μονοκλωνικα αντισωματα εναντι του αναστολεα της οδου του ιστικου παραγοντα (tfpi) | |
BR112016000561B8 (pt) | Compostos terapeuticamente ativos, uso dos mesmos, composição farmacêutica e uso da mesma | |
EA201691079A1 (ru) | Комбинированная терапия для лечения онкологического заболевания | |
EA201490647A1 (ru) | Производные бензотиазол-6-илуксусной кислоты и их применение для лечения вич-инфекции |